The American Academy of Ophthalmology stated that is commends the US House of Representatives for surpassing the 290-cosponsor milestone in support of H.R. 3173, the "Improving Seniors’ Timely Access to Care Act of 2021."
Spark Therapeutics, a part of the Roche Group, announced that Ron Philip, the company's COO, will take over as CEO from co-founder Jeffrey D. Marrazzo. Mr. Marrazzo, who joined the company as a co-founder in 2013, will step down on April 1.
Rayner announced that it has entered into a commercial partnership and concurrently acquired a stake in Hasa Optix, a Brussels-based manufacturer of single use ophthalmic surgical instruments and instrument sets.
VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, is readying to share the first clinical experiences of AcrivaUD Trinova Pro C Pupil Adaptive®.
Omeros has completed the sale of Omidria (phenylephrine and ketorolac intraocular solution) 1.0%/0.3% to Rayner Surgical Group.
AffaMed Therapeutics and Hanmi Pharmaceutical Co. have entered into a licensing agreement, according to a company news release.
France-based Moria has acquired Italian-based company Alchimia SRL, a manufacturer of devices for ophthalmic surgery and human tissue banking.
Retina Consultants of America (RCA), a physician management services organization, has added Retina Center Northwest (RCNW) in Washington state,.
Retina Consultants of America (RCA) has added Associated Vitreoretinal and Uveitis Consultants (AVRUC) to its national consortium.
The US Department of Defense (DoD) has awarded Weill Cornell Medicine a $1.27 million grant to develop a treatment for a rare but deadly eye disease that mostly affects military members who have suffered traumatic eye injuries in combat.